摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

m-methylbenzyl tosylate | 14503-41-4

中文名称
——
中文别名
——
英文名称
m-methylbenzyl tosylate
英文别名
3-MeC6H4CH2OTs;toluene-4-sulfonic acid-(3-methyl-benzyl ester);Toluol-4-sulfonsaeure-(3-methyl-benzylester);p-Toluolsulfonsaeure-(3-methyl-benzylester);m-Methyl-benzyltosylat;(3-Methylphenyl)methyl 4-methylbenzene-1-sulfonate;(3-methylphenyl)methyl 4-methylbenzenesulfonate
m-methylbenzyl tosylate化学式
CAS
14503-41-4
化学式
C15H16O3S
mdl
——
分子量
276.356
InChiKey
MJKYTDUUYZAMLJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    19
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    51.8
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    m-methylbenzyl tosylate 在 sodium azide 作用下, 以 四氢呋喃 为溶剂, 反应 2.0h, 生成 3-甲基苄基叠氮
    参考文献:
    名称:
    Simple and Efficient Method for the Synthesis of Azides in Water-THF Solvent System
    摘要:
    DOI:
    10.1080/00304948.2011.594002
  • 作为产物:
    描述:
    参考文献:
    名称:
    Acetolysis reactivities of substituted benzyl and polycyclic arylmethyl p-toluenesulfonates. Correlations with SCF [self-consistant field]-.pi. and CNDO [complete neglect of differential overlap] MO methods
    摘要:
    DOI:
    10.1021/ja00720a025
点击查看最新优质反应信息

文献信息

  • N-heterocyclic carbene–palladium(<scp>ii</scp>)-1-methylimidazole complex-catalyzed Suzuki–Miyaura coupling of benzyl sulfonates with arylboronic acids
    作者:Xiao-Xia Wang、Bin-Bin Xu、Wen-Ting Song、Kai-Xin Sun、Jian-Mei Lu
    DOI:10.1039/c4ob02675f
    日期:——

    The first example of palladium-catalyzed coupling between benzyl sulfonates and arylboronic acids was reported.

    第一个钯催化的苯甲基磺酸酯和芳基硼酸之间的偶联反应的例子被报道了。
  • Anilides related to substituted benzamides. Potential antipsychotic activity of N-(4-amino-5-chloro-2-methoxyphenyl)-1-(phenylmethyl)-4-piperidinecarboxamide
    作者:Frank E. Blaney、Michael S. G. Clark、Derek V. Gardner、Michael S. Hadley、David Middleton、Trevor J. White
    DOI:10.1021/jm00366a017
    日期:1983.12
    The substituted benzamides are used clinically both as antipsychotics and as stimulants of gastric motility. The antipsychotic effects are considered to be a consequence of their central dopamine antagonist properties, but there is evidence that the gastric stimulatory effects may be mediated by other mechanisms. Clebopride (3) is a substituted benzamide that although marketed for its stimulatory effects
    取代的苯甲酰胺在临床上既用作抗精神病药,又用作胃动力的兴奋剂。抗精神病作用被认为是其中央多巴胺拮抗剂特性的结果,但是有证据表明,胃刺激作用可能是由其他机制介导的。Clebopride(3)是一种取代的苯甲酰胺,尽管因其对胃蠕动的刺激作用而上市,但它也是有效的中枢多巴胺拮抗剂。已合成了酰胺键已被逆转的相应的苯胺化物BRL 20596(4a),发现其缺乏胃刺激活性。但是,有效的中枢多巴胺拮抗剂活性得以保留,表明苯甲酰胺和苯胺对中枢多巴胺受体具有相似的亲和力。讨论了在这些受体上苯甲酰胺和苯甲酰胺采用的构象的含义。也有证据表明,在这类受体上还有一个亲脂性结合位点,N-苄基最适合。
  • Catalyst and process for preparing low-viscosity and color-reduced polyisocyanates containing isocyanurate groups
    申请人:DEGUSSA AG
    公开号:US20030187178A1
    公开(公告)日:2003-10-02
    A low-viscosity polyisocyanates and polyisocyanates of reduced color containing isocyanurate groups is prepared by a process comprising, partially trimerizing aliphatic and/or cycloaliphatic diisocyanates in the presence of 0.02 to 2% by weight, based on the weight of the diisocyanate starting material, of at least one trimerization catalyst of formula (I) 1 wherein and wherein substituents A, B, C, D, and E simultaneously or independently of one another are hydrogen, chloro, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxycarbonyl, hydroxyl, (R 5 ) 3 SiO—, (R 5 ) 2 N—, —COOH, (R 5 ) 2 N—CH 2 — or phenyl, it being 5 possible for any two adjacent radicals selected from the group A, B, C, D and E to form a conjoint 5- or 6-membered saturated or unsaturated ring which may also include nitrogen, sulfur or oxygen heteroatoms; F is hydrogen, methyl or fluoro; G is hydrogen, methyl or fluoro; R 2 and R 3 simultaneously or independently of one another are C 1 -C 18 -alkyl or R 1 ; R 4 is hydrogen, methyl, C 2 -C 18 -alkyl, C 3 -C 8 -cycloalkyl or C 2 -C 12 -alkoxy; R 5 is C 1 -C 18 -alkyl; Y − is R 6 COO − ; R 6 is hydrogen or a branched or unbranched aliphatic or araliphatic C 1 -C 12 -alkyl radical, and then removing excess diisocyanate from the reaction medium.
    通过部分三聚脂肪族和/或环脂肪族二异氰酸酯在至少一种式(I)的三聚催化剂的存在下进行部分三聚化反应,其中所述催化剂的重量为二异氰酸酯起始物的重量的0.02至2%。所述催化剂的式子如下:其中,取代基A、B、C、D和E可以同时或独立地是氢、氯、C1-C4-烷基、C1-C4-烷氧基、C1-C4-烷氧羰基、羟基、(R5)3SiO-、(R5)2N-、-COOH、(R5)2N-CH2-或苯基,其中任意相邻的两个基团A、B、C、D和E中选择的基团可以形成共轭的5-或6-成员饱和或不饱和环,该环还可以包括氮、硫或氧杂原子;F为氢、甲基或氟;G为氢、甲基或氟;R2和R3可以同时或独立地是C1-C18烷基或R1;R4为氢、甲基、C2-C18烷基、C3-C8环烷基或C2-C12烷氧基;R5为C1-C18烷基;Y-为R6COO-;R6为氢或支链或非支链的脂肪族或芳基脂肪族C1-C12烷基基团,然后从反应介质中去除多余的二异氰酸酯,从而制备含有异氰酸酯基团的低粘度聚异氰酸酯和降低颜色的聚异氰酸酯。
  • SSAO INHIBITOR
    申请人:Shandong Danhong Pharmaceutical Co., Ltd.
    公开号:EP3626699A1
    公开(公告)日:2020-03-25
    The present invention provides an SSAO inhibitor and an application thereof in preparing a drug for treating a disease related to SSAO. In particular, the present invention provides a compound shown in formula (IV) and a pharmaceutically acceptable salt thereof.
    本发明提供了一种SSAO抑制剂及其在制备治疗与SSAO相关疾病的药物中的应用。特别是,本发明提供了一种式(IV)所示的化合物及其药学上可接受的盐。
  • Base-promoted N-alkylation using formamides as the N-sources in neat water
    作者:Wen-Xin Chen、Cai-Yun Zhang、Li-Xiong Shao
    DOI:10.1016/j.tet.2013.12.031
    日期:2014.1
    An efficient catalyst-free, alternative method for the C-N bond formation reaction of alkyl electrophiles using formamides as the N-sources was achieved under mild conditions. The reaction possesses the advantages of a broad range of substrates scope and wide functional group tolerance. It should also be noted that this process was performed using the environmentally benign water as the sole solvent, and high yield can also be achieved in ten-gram scale. (C) 2013 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐